SCHEMBL14488207

SCHEMBL14488207

COc1ccc(CCN2CCN(c3nc(-c4ccc(F)cc4)ns3)CC2)cc1.COc1cccc(CCN2CCN(c3nc(-c4cccc(Cl)c4)ns3)CC2)c1

nearest known ligand 0.47

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.47
SIGMAR1 Q99720 2/20 0.45
HTR1A P08908 1/20 0.44
ABCB1 P08183 4/20 0.43
DRD2 P14416 1/20 0.43
DRD4 P21917 1/20 0.43
ADRA1D P25100 2/20 0.42
ADRA1A P35348 2/20 0.42
ADRA1B P35368 2/20 0.42
HRH3 Q9Y5N1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14488116 1.00 FAAH (0.47) FAAHSIGMAR1HTR1AABCB1DRD2
SCHEMBL14486551 0.91 SIGMAR1 (0.55) FAAHSIGMAR1HTR1AABCB1DRD2
SCHEMBL14486293 0.90 SIGMAR1 (0.56) FAAHSIGMAR1HTR1AABCB1ADRA1D
SCHEMBL14486549 0.90 FAAH (0.48) FAAHSIGMAR1ADRA1DADRA1AADRA1B
SCHEMBL14486590 0.89 FAAH (0.50) FAAHSIGMAR1DRD2DRD4
SCHEMBL14486576 0.88 DRD2 (0.53) FAAHSIGMAR1HTR1ADRD2DRD4
SCHEMBL14486342 0.88 FAAH (0.48) FAAHSIGMAR1HTR1ADRD2DRD4
SCHEMBL14486394 0.88 SIGMAR1 (0.59) FAAHSIGMAR1HTR1AADRA1DADRA1A
SCHEMBL14486630 0.87 SIGMAR1 (0.56) FAAHSIGMAR1HTR1ADRD2DRD4
SCHEMBL14486056 0.87 SIGMAR1 (0.52) FAAHSIGMAR1ADRA1DADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2726470-A1 1, 2, 4 -THIADIAZOL- 5 -YLPIPERAZINE DERIVATIVES USEFUL IN THE TREATMENT NEURODEGENERATIVE DISEASES reMynd NV (BE) 2014-05-07 EP disclosed
WO-2013004642-A1 1, 2, 4 -THIADIAZOL- 5 -YLPIPERAZINE DERIVATIVES USEFUL IN THE TREATMENT NEURODEGENERATIVE DISEASES REMYND NV (BE) 2013-01-10 WO disclosed